ZUH:CA:TSX-BMO Equal Weight US Health Care (CAD Hedged) (CAD)

ETF | Sector Equity |

Last Closing

CAD 70.89

Change

+0.32 (+0.45)%

Market Cap

CAD 0.26B

Volume

1.60K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-07 )

Largest Industry Peers for Sector Equity

Symbol Name Price(Change) Market Cap
TEC:CA TD Global Technology Leaders I..

+0.48 (+1.10%)

CAD 3.04B
ZWU:CA BMO Covered Call Utilities ETF

-0.02 (-0.18%)

CAD 1.92B
XIT:CA iShares S&P/TSX Capped Informa..

+1.05 (+1.72%)

CAD 0.66B
TXF:CA First Asset Tech Giants Covere..

+0.36 (+1.62%)

CAD 0.65B
HTA:CA Harvest Tech Achievers Growth ..

+0.34 (+1.76%)

CAD 0.64B
XHC:CA iShares Global Healthcare (CAD..

+0.52 (+0.72%)

CAD 0.63B
ZUT:CA BMO Equal Weight Utilities Ind..

+0.11 (+0.50%)

CAD 0.55B
CWW:CA iShares Global Water Common Cl..

-0.53 (-0.89%)

CAD 0.33B
XUT:CA iShares S&P/TSX Capped Utiliti..

-0.03 (-0.11%)

CAD 0.33B
COW:CA iShares Global Agriculture Com..

-0.98 (-1.47%)

CAD 0.28B

ETFs Containing ZUH:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Sector Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.96% 17% F 29% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.96% 17% F 29% F
Trailing 12 Months  
Capital Gain 17.50% 43% F 50% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 17.50% 43% F 50% F
Trailing 5 Years  
Capital Gain 26.45% 37% F 57% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 26.45% 37% F 57% F
Average Annual (5 Year Horizon)  
Capital Gain 4.54% 31% F 51% F
Dividend Return 4.92% 26% F 49% F
Total Return 0.38% 28% F 27% F
Risk Return Profile  
Volatility (Standard Deviation) 16.33% 63% D 52% F
Risk Adjusted Return 30.11% 29% F 48% F
Market Capitalization 0.26B 71% C- 50% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.